Insider · CIK 0001234346
Gerald M Lieberman
director
Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD), ENTX (Entera Bio Ltd.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares | +9,632 | - | - | 115,657 | Jun 9, 2025 |
| Jun 6, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative | -9,632 | $0.00 | $0 | 0 | Jun 9, 2025 |
| Jun 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | AGrant or award Restricted Share Unitsderivative | +14,492 | $0.00 | $0 | 14,492 | Jun 9, 2025 |
| Apr 1, 2025 | ENTX Entera Bio Ltd. | MOption exercise Ordinary Shares, par value NIS 0.0000769 per share | +23,952 | $1.00 | $24k | 300,160 | Apr 3, 2025 |
| Apr 1, 2025 | ENTX Entera Bio Ltd. | MOption exercise Warrant (right to buy)derivative | -23,952 | $0.00 | $0 | 28,509 | Apr 3, 2025 |
| Jan 15, 2025 | ENTX Entera Bio Ltd. | AGrant or award Ordinary Shares, par value NIS 0.0000769 per share | +10,717 | $0.00 | $0 | 276,208 | Jan 17, 2025 |
| Jan 15, 2025 | ENTX Entera Bio Ltd. | AGrant or award Stock Option (right to buy)derivative | +28,509 | $0.00 | $0 | 28,509 | Jan 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.